Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

NCT06482554 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center Shreveport as lead sponsor.

NCT NCT06482554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Lead sponsor
Louisiana State University Health Sciences Center Shreveport
Phase
Phase 3
Overall status
Recruiting
Start date
June 30, 2024
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

apathy, schizophrenia, schizophrenia; psychosis